Effects of cladribine tablets on lymphocyte subsets in patients with multiple sclerosis: an extended analysis of surface markers.

Olaf StüvePer Soelberg SoerensenThomas LeistGavin GiovannoniYann HyvertDoris DamianFernando DangondUrsula Boschert

Published in: Therapeutic advances in neurological disorders (2019)

CT3.5 has comparable effects on the immune systems of patients with CIS or RRMS. The pronounced reduction and recovery dynamics of CD19+ B cells and relative changes in the proportion of some immune cell subtypes may underlie the clinical effects of CT3.5.

Keyphrases

image quality
dual energy
computed tomography
contrast enhanced
peripheral blood
positron emission tomography
magnetic resonance